PROMOTING ACCESS TO AFRICAN RESEARCH

African Health Sciences

Log in or Register to get access to full text downloads.

Remember me or Register



Rectus sheath hematoma and retroperitoneal bleeding due to rivaroxaban: a case report

Elif Börekci

Abstract


Rivaroxaban is one of the new anti-coagulants that inhibit Factor Xa and rarely cause rectus sheath hematoma and retroperitoneal haemorrhage which are uncommon, life-threatening complications. Here is a case of an elderly patient on rivaroxaban therapy for the stroke prevention in non-valvular atrial fibrillation who developed rectus sheath hematoma and retroperitoneal bleeding.

Keywords: Rectus sheath hematoma, retroperitoneal bleeding, rivaroxaban.




http://dx.doi.org/10.4314/ahs.v19i2.55
AJOL African Journals Online